58
Supporting information Differential characterization using readily accessible NMR experiments of novel N- and O- alkylated quinolin-4-ol, 1,5-naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity Eleni Pitta 1 , Olga Balabon 1 , Maciej K. Rogacki 1 , Jesús Gómez 2 , Fraser Cunningham 2 , Koen Augustyns 1 , Jurgen Joosens 1 , Pieter van der Veken 1,* , Robert Bates 2,* 1 Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp, Universitieitsplein 1, B-2610 Wilrijk, Belgium 2 Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain

1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

  • Upload
    others

  • View
    1

  • Download
    0

Embed Size (px)

Citation preview

Page 1: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Supporting information

Differential characterization using readily accessible NMR experiments of novel N- and O-alkylated quinolin-4-ol, 1,5-

naphthyridin-4-ol and quinazolin-4-ol derivatives with antimycobacterial activity

Eleni Pitta1, Olga Balabon1, Maciej K. Rogacki1, Jesús Gómez2, Fraser Cunningham2, Koen

Augustyns1, Jurgen Joosens1, Pieter van der Veken1,*, Robert Bates2,*

1Medicinal Chemistry, Department of Pharmaceutical Sciences, University of Antwerp,

Universitieitsplein 1, B-2610 Wilrijk, Belgium

2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus

(TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain

Page 2: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Table of ContentsCompound 9a.............................................................................................................................................4

1H-NMR....................................................................................................................................................413C-NMR...................................................................................................................................................4

HSQC........................................................................................................................................................5

HMBC.......................................................................................................................................................6

COSY........................................................................................................................................................7

NOE.........................................................................................................................................................8

Compound 9b..............................................................................................................................................91H-NMR....................................................................................................................................................913C-NMR...................................................................................................................................................9

HSQC......................................................................................................................................................10

HMBC.....................................................................................................................................................11

NOE........................................................................................................................................................12

Compound 9c............................................................................................................................................131H-NMR..................................................................................................................................................1313C-NMR.................................................................................................................................................13

HSQC......................................................................................................................................................14

HMBC.....................................................................................................................................................15

NOE........................................................................................................................................................16

Compound 13a..........................................................................................................................................171H-NMR..................................................................................................................................................1713C-NMR.................................................................................................................................................17

HSQC......................................................................................................................................................18

HMBC.....................................................................................................................................................19

COSY......................................................................................................................................................20

NOE........................................................................................................................................................21

Compound 13b..........................................................................................................................................221H-NMR..................................................................................................................................................2213C-NMR.................................................................................................................................................22

HSQC......................................................................................................................................................23

Page 3: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC.....................................................................................................................................................24

NOE........................................................................................................................................................25

Compound 17............................................................................................................................................261H-NMR..................................................................................................................................................2613C-NMR.................................................................................................................................................26

HSQC......................................................................................................................................................27

HMBC.....................................................................................................................................................28

Compound 21a..........................................................................................................................................291H-NMR..................................................................................................................................................2913C-NMR.................................................................................................................................................29

HSQC......................................................................................................................................................30

HMBC.....................................................................................................................................................31

COSY......................................................................................................................................................32

NOE........................................................................................................................................................33

Compound 21b..........................................................................................................................................341H-NMR..................................................................................................................................................3413C-NMR.................................................................................................................................................34

HSQC......................................................................................................................................................35

HMBC.....................................................................................................................................................36

NOE........................................................................................................................................................37

Compound 21c..........................................................................................................................................381H-NMR..................................................................................................................................................3813C-NMR.................................................................................................................................................38

HSQC......................................................................................................................................................39

HMBC.....................................................................................................................................................40

NOE........................................................................................................................................................41

Compound 23............................................................................................................................................431H-NMR..................................................................................................................................................4313C-NMR.................................................................................................................................................43

HSQC......................................................................................................................................................44

HMBC.....................................................................................................................................................45

NOE........................................................................................................................................................46

Page 4: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 9a1H-NMR

Page 5: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 6: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 7: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 8: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

COSY

Page 9: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 10: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 9b1H-NMR

Page 11: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 12: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 13: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 14: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 15: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 9c1H-NMR

Page 16: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 17: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 18: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 19: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 20: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 13a1H-NMR

Page 21: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 22: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 23: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 24: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

COSY

Page 25: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 26: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 13b1H-NMR

Page 27: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 28: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 29: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 30: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 31: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 171H-NMR

13C-NMR

Page 32: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 33: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 34: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 21a1H-NMR

Page 35: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 36: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 37: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 38: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

COSY

Page 39: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 40: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 21b1H-NMR

13C-NMR

Page 41: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 42: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 43: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 44: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 21c1H-NMR

Page 45: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 46: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 47: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 48: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

COSY

Page 49: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE

Page 50: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

Compound 231H-NMR

Page 51: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

13C-NMR

Page 52: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HSQC

Page 53: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

HMBC

Page 54: 1H-NMR · Web view2Diseases of the Developing World (DDW), Tres Cantos Medicines Development Campus (TCMDC), GlaxoSmithKline, Severo Ochoa 2, 28760, Tres Cantos Madrid, Spain Table

NOE